Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AVA (Augmented Vascular Analysis)

K-Number: K201369 · 2020-09-16

Decision Date2020-09-16
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

AVA (Augmented Vascular Analysis) is the device name listed in this FDA 510(k) record. The listed applicant is See-Mode Technologies Pte, Ltd.. It received FDA 510(k) clearance on 2020-09-16 under 510(k) number K201369. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AVA (Augmented Vascular Analysis)?

AVA (Augmented Vascular Analysis) is a medical device that received FDA 510(k) clearance on 2020-09-16. The listed applicant is See-Mode Technologies Pte, Ltd.. The 510(k) number is K201369.

When did AVA (Augmented Vascular Analysis) receive FDA 510(k) clearance?

AVA (Augmented Vascular Analysis) received FDA 510(k) clearance on 2020-09-16, under 510(k) number K201369.

Who is the listed applicant for AVA (Augmented Vascular Analysis)?

The FDA 510(k) record lists See-Mode Technologies Pte, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AVA (Augmented Vascular Analysis)?

The FDA product code for AVA (Augmented Vascular Analysis) is LLZ.

Other records listing See-Mode Technologies Pte, Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.